Low molecular weight dextran sulfate as complement inhibitor and cytoprotectant in solid organ and islet transplantation

Molecular Immunology
Rolf SpirigRobert Rieben

Abstract

Complement is an essential part of the innate immune system and plays a crucial role in organ and islet transplantation. Its activation, triggered for example by ischemia/reperfusion (I/R), significantly influences graft survival, and blocking of complement by inhibitors has been shown to attenuate I/R injury. Another player of innate immunity are the dendritic cells (DC), which form an important link between innate and adaptive immunity. DC are relevant in the induction of an immune response as well as in the maintenance of tolerance. Modulation or inhibition of both components, complement and DC, may be crucial to improve the clinical outcome of solid organ as well as islet transplantation. Low molecular weight dextran sulfate (DXS), a well-known complement inhibitor, has been shown to prevent complement-mediated damage of the donor graft endothelium and is thus acting as an endothelial protectant. In this review we will discuss the evidence for this cytoprotective effect of DXS and also highlight recent data which show that DXS inhibits the maturation of human DC. Taken together the available data suggest that DXS may be a useful reagent to prevent the activation of innate immunity, both in solid organ and islet transplantat...Continue Reading

References

Mar 1, 1978·The Journal of Clinical Investigation·P R MarokoS L Hale
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·F B PetersenK M Sullivan
Apr 1, 1990·The Journal of Experimental Medicine·J L PlattA P Dalmasso
Dec 1, 1988·Transplant International : Official Journal of the European Society for Organ Transplantation·M StoffelG P Alexandre
Nov 15, 1988·The Biochemical Journal·K KarlssonS L Marklund
Jul 1, 1984·The Journal of Clinical Investigation·R D Rosenberg, J S Rosenberg
Sep 1, 1995·The Journal of Cell Biology·M S DiamondT A Springer
Jul 14, 1995·The Journal of Biological Chemistry·T F ZioncheckR J Stack
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Apr 15, 1994·Transplantation·L E WrenshallJ L Platt
Oct 1, 1995·Biomaterials·H ThomasM D Kazatchkine
Dec 20, 1996·The Journal of Biological Chemistry·E KaczmarekS C Robson
Mar 1, 1997·American Journal of Respiratory and Critical Care Medicine·A SalvatierraR Guerrero
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Apr 4, 1998·Brain Research Bulletin·U S VasthareR F Tuma
May 8, 1998·Journal of Cellular Physiology·N S IhrckeJ L Platt
Sep 25, 1999·Journal of Leukocyte Biology·L E WrenshallJ L Platt

❮ Previous
Next ❯

Citations

Aug 6, 2013·Current Diabetes Reports·Antonio CitroLorenzo Piemonti
Feb 13, 2010·Xenotransplantation·Shuji MiyagawaMasahiro Fukuzawa
May 21, 2014·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·W J HawthorneP J Cowan
Apr 24, 2015·Transplant International : Official Journal of the European Society for Organ Transplantation·Simen W SchiveTrond G Jenssen
Nov 1, 2011·Microvascular Research·Erik SvensjöJulio Scharfstein
Mar 20, 2014·Expert Opinion on Therapeutic Patents·Enrique L Larghi, Teodoro S Kaufman
May 15, 2015·Bioconjugate Chemistry·Christina N M RyanDimitrios I Zeugolis
Apr 13, 2010·Expert Review of Clinical Immunology·Jamil AzziReza Abdi
Oct 6, 2011·Current Opinion in Organ Transplantation·Bo NilssonOlle Korsgren
Feb 24, 2017·Journal of Pediatric Gastroenterology and Nutrition·Melena D BellinSrinath Chinnakotla
Mar 7, 2020·Proceedings of the National Academy of Sciences of the United States of America·Tung-Ching HoDing-Shinn Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.